Life Sci Cos. Should Work With FDA To Shape AI Regulation
Artificial intelligence tools present groundbreaking opportunities in the development of drugs and biologics and in manufacturing these medicinal products, with the potential for streamlining drug development and improving health outcomes through...To view the full article, register now.
Already a subscriber? Click here to view full article